<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=SPRED1</id>
	<title>SPRED1 - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=SPRED1"/>
	<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=SPRED1&amp;action=history"/>
	<updated>2026-04-25T09:36:10Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://wikimd.org/index.php?title=SPRED1&amp;diff=5380340&amp;oldid=prev</id>
		<title>Prab: CSV import</title>
		<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=SPRED1&amp;diff=5380340&amp;oldid=prev"/>
		<updated>2024-03-10T07:29:53Z</updated>

		<summary type="html">&lt;p&gt;CSV import&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;&amp;#039;&amp;#039;&amp;#039;SPRED1&amp;#039;&amp;#039;&amp;#039; is a gene that in humans is encoded by the SPRED1 protein. It is a member of the Sprouty/SPRED family of proteins and is involved in cellular processes such as [[cell proliferation]] and [[cell migration]]. Mutations in this gene have been associated with a neurofibromatosis phenotype characterized by [[legius syndrome]].&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
The SPRED1 protein is a negative regulator of the [[Ras-MAPK pathway]], a signaling pathway that controls cell growth and differentiation. It functions by inhibiting the activation of [[Raf]], a key component of the Ras-MAPK pathway. This inhibition is achieved through the interaction of SPRED1 with [[neurofibromin 1]], another negative regulator of the Ras-MAPK pathway.&lt;br /&gt;
&lt;br /&gt;
== Clinical significance ==&lt;br /&gt;
Mutations in the SPRED1 gene are associated with a condition known as Legius syndrome, also known as neurofibromatosis type 1-like syndrome. This condition is characterized by multiple [[café-au-lait spots]], skin fold freckling, and a predisposition to certain types of tumors. Individuals with Legius syndrome also have an increased risk of learning disabilities and attention deficit disorder.&lt;br /&gt;
&lt;br /&gt;
== Research ==&lt;br /&gt;
Research into the SPRED1 gene and its associated protein has potential implications for the treatment of diseases such as cancer. By understanding how SPRED1 regulates the Ras-MAPK pathway, it may be possible to develop therapies that can modulate this pathway and inhibit tumor growth.&lt;br /&gt;
&lt;br /&gt;
== See also ==&lt;br /&gt;
* [[Sprouty gene]]&lt;br /&gt;
* [[Ras-MAPK pathway]]&lt;br /&gt;
* [[Legius syndrome]]&lt;br /&gt;
* [[Neurofibromatosis]]&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Genes]]&lt;br /&gt;
[[Category:Proteins]]&lt;br /&gt;
[[Category:Medical genetics]]&lt;br /&gt;
[[Category:Oncology]]&lt;br /&gt;
{{medicine-stub}}&lt;/div&gt;</summary>
		<author><name>Prab</name></author>
	</entry>
</feed>